First FDA-Approved Study of Cord Blood to Treat Hearing Loss

You are here

First FDA-Approved Study of Cord Blood to Treat Hearing Loss

Fri, 01/13/2012

HOUSTON -- January 12, 2012 -- Children’s Memorial Hermann Hospital and Cord Blood Registry® (CBR) are launching the first FDA-approved, Phase I safety study on the use of cord blood stem cells to treat children with sensorineural hearing loss.  View the press release.